Biologic drug offers promising protection against alpha-gal syndrome
The summer of 2026 was a particularly bad season for ticks. And with it came a rising number of cases of alpha-gal syndrome (AGS) thanks to bites from the Lone Star Tick.
Read original article on The Medical News →Related news
-
Scientists identify protein driving age-related organ damage
United Kingdom
-
College student mental health improves, but significant needs remain
United Kingdom
-
Stocking epinephrine in schools protects students and eases family financial burdens
United Kingdom
-
Language barriers delay early peanut introduction for many infants
United Kingdom
-
Study reveals frequent insurance denials for pediatric biologic allergy treatments
United Kingdom
-
Biologic drug for eosinophilic esophagitis lowers childhood asthma risk
United Kingdom
-
Blood thinner could offer a new way to treat osteoarthritis
United Kingdom
-
Three decision-making styles emerge when people weigh probability words against numbers, researchers report
United Kingdom